Discover the new Chem-Impex: Where innovation starts with a bond.

Catalog Number:
38085
CAS Number:
65271-80-9
Mitoxantrone
Purity:
≥ 97% (HPLC)
Synonym(s):
1,4-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]anthraquinone, 1,4-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]anthracene-9,10-dione
Hazmat
Documents
$97.25 /200MG
Pack Size Availability Price
Request Bulk Quote
Product Information
Synonyms
1,4-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]anthraquinone, 1,4-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]anthracene-9,10-dione
CAS Number
65271-80-9
Purity
≥ 97% (HPLC)
Molecular Formula
C22H28N4O6
Molecular Weight
0
MDL Number
MFCD00242942
PubChem ID
4212
Melting Point
170 - 174 °C
Appearance
Light yellow to amber to dark green powder to crystal
Conditions
Store at < -20 °C
General Information
Synonyms
1,4-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]anthraquinone, 1,4-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]anthracene-9,10-dione
CAS Number
65271-80-9
Purity
≥ 97% (HPLC)
Molecular Formula
C22H28N4O6
Molecular Weight
0
MDL Number
MFCD00242942
PubChem ID
4212
Melting Point
170 - 174 °C
Appearance
Light yellow to amber to dark green powder to crystal
Conditions
Store at < -20 °C
Properties
Additional property information coming soon!
-
Safety and Regulations
Hazmat
Yes
Antibiotic
No
DEA-regulated
No
Warnings
-
Applications

Mitoxantrone is widely utilized in research focused on:

  • Cancer Treatment: This compound is primarily used as a chemotherapy agent for treating various types of cancer, including leukemia and breast cancer. It works by interfering with the DNA of cancer cells, preventing their growth and reproduction.
  • Multiple Sclerosis Therapy: Mitoxantrone is also employed in the treatment of multiple sclerosis (MS). It helps reduce the frequency of relapses and slows the progression of disability in patients.
  • Cardiotoxicity Research: Researchers study the cardiotoxic effects of mitoxantrone to better understand its impact on heart health, which can lead to improved patient management strategies during chemotherapy.
  • Combination Therapy Studies: It is often used in combination with other drugs to enhance therapeutic efficacy. This approach allows researchers to explore synergistic effects and optimize treatment regimens for better outcomes.
  • Pharmaceutical Development: Mitoxantrone serves as a model compound in drug formulation studies, helping scientists develop more effective delivery systems and dosage forms for cancer therapies.

Citations